210 related articles for article (PubMed ID: 30549245)
1. Persons living with HIV with advanced HIV disease: need for novel care models.
Teasdale CA; Yuengling K; Preko P; Syowai M; Ndagije F; Rabkin M; Abrams EJ; El-Sadr WM
J Int AIDS Soc; 2018 Dec; 21(12):e25210. PubMed ID: 30549245
[TBL] [Abstract][Full Text] [Related]
2. Expansion and scale-up of HIV care and treatment services in four countries over ten years.
Teasdale CA; Abrams EJ; Yuengling KA; Lamb MR; Wang C; Vitale M; Hawken M; Melaku Z; Nuwagaba-Biribonwoha H; El-Sadr WM
PLoS One; 2020; 15(4):e0231667. PubMed ID: 32298331
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
[TBL] [Abstract][Full Text] [Related]
4. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
[TBL] [Abstract][Full Text] [Related]
5. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
Alvarez-Uria G; Naik PK; Pakam R; Midde M
Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
[TBL] [Abstract][Full Text] [Related]
7. High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique.
Molfino L; Kumar AM; Isaakidis P; Van den Bergh R; Khogali M; Hinderaker SG; Magaia A; Lobo S; Edwards CG; Walter J
Glob Health Action; 2014; 7():23758. PubMed ID: 24717189
[TBL] [Abstract][Full Text] [Related]
8. Predictors of attrition among adults in a rural HIV clinic in southern Mozambique: 18-year retrospective study.
Nacarapa E; Verdu ME; Nacarapa J; Macuacua A; Chongo B; Osorio D; Munyangaju I; Mugabe D; Paredes R; Chamarro A; Revollo B; Alexandre SS; Simango M; Torrus D; Ramos-Rincon JM
Sci Rep; 2021 Sep; 11(1):17897. PubMed ID: 34504234
[TBL] [Abstract][Full Text] [Related]
9. Determinants of mortality and loss to follow-up among adults enrolled in HIV care services in Rwanda.
Mugisha V; Teasdale CA; Wang C; Lahuerta M; Nuwagaba-Biribonwoha H; Tayebwa E; Ingabire E; Ingabire P; Sahabo R; Twyman P; Abrams EJ;
PLoS One; 2014; 9(1):e85774. PubMed ID: 24454931
[TBL] [Abstract][Full Text] [Related]
10. Determinants of time to antiretroviral treatment initiation and subsequent mortality on treatment in a cohort in rural northern Malawi.
Brown JP; Ngwira B; Tafatatha T; Crampin AC; French N; Koole O
AIDS Res Ther; 2016; 13():24. PubMed ID: 27398087
[TBL] [Abstract][Full Text] [Related]
11. Characteristics and outcomes of adult Ethiopian patients enrolled in HIV care and treatment: a multi-clinic observational study.
Melaku Z; Lamb MR; Wang C; Lulseged S; Gadisa T; Ahmed S; Habtamu Z; Alemu H; Assefa T; Abrams EJ
BMC Public Health; 2015 May; 15():462. PubMed ID: 25934178
[TBL] [Abstract][Full Text] [Related]
12. Gender differences in survival among adult patients starting antiretroviral therapy in South Africa: a multicentre cohort study.
Cornell M; Schomaker M; Garone DB; Giddy J; Hoffmann CJ; Lessells R; Maskew M; Prozesky H; Wood R; Johnson LF; Egger M; Boulle A; Myer L;
PLoS Med; 2012; 9(9):e1001304. PubMed ID: 22973181
[TBL] [Abstract][Full Text] [Related]
13. Characteristics and outcomes of HIV-infected youth and young adolescents enrolled in HIV care in Kenya.
Koech E; Teasdale CA; Wang C; Fayorsey R; Alwar T; Mukui IN; Hawken M; Abrams EJ
AIDS; 2014 Nov; 28(18):2729-38. PubMed ID: 25493599
[TBL] [Abstract][Full Text] [Related]
14. Trends in clinical characteristics and outcomes of Pre-ART care at a large HIV clinic in Nairobi, Kenya: a retrospective cohort study.
Mecha JO; Kubo EN; Nganga LW; Muiruri PN; Njagi LN; Mutisya IN; Odionyi JJ; Ilovi SC; Wambui M; Githu C; Ngethe R; Obimbo EM; Ngumi ZW
AIDS Res Ther; 2016; 13():38. PubMed ID: 27895697
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with late antiretroviral therapy initiation among adults in Mozambique.
Lahuerta M; Lima J; Nuwagaba-Biribonwoha H; Okamura M; Alvim MF; Fernandes R; Assan A; Hoos D; Elul B; El-Sadr WM; Nash D
PLoS One; 2012; 7(5):e37125. PubMed ID: 22615917
[TBL] [Abstract][Full Text] [Related]
16. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
[TBL] [Abstract][Full Text] [Related]
17. Retention of HIV-infected children on antiretroviral treatment in HIV care and treatment programs in Kenya, Mozambique, Rwanda, and Tanzania.
McNairy ML; Lamb MR; Carter RJ; Fayorsey R; Tene G; Mutabazi V; Gusmao E; Panya M; Sheriff M; Abrams EJ;
J Acquir Immune Defic Syndr; 2013 Mar; 62(3):e70-81. PubMed ID: 23111575
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Treatment Failure among Adult Antiretroviral Treatment (ART) Clients in Bale Zone Hospitals, South Eastern Ethiopia.
Haile D; Takele A; Gashaw K; Demelash H; Nigatu D
PLoS One; 2016; 11(10):e0164299. PubMed ID: 27716827
[TBL] [Abstract][Full Text] [Related]
19. Attrition when providing antiretroviral treatment at CD4 counts >500cells/μL at three government clinics included in the HPTN 071 (PopART) trial in South Africa.
Bock P; Fatti G; Ford N; Jennings K; Kruger J; Gunst C; Louis F; Grobbelaar N; Shanaube K; Floyd S; Grimwood A; Hayes R; Ayles H; Fidler S; Beyers N;
PLoS One; 2018; 13(4):e0195127. PubMed ID: 29672542
[TBL] [Abstract][Full Text] [Related]
20. High attrition before and after ART initiation among youth (15-24 years of age) enrolled in HIV care.
Lamb MR; Fayorsey R; Nuwagaba-Biribonwoha H; Viola V; Mutabazi V; Alwar T; Casalini C; Elul B
AIDS; 2014 Feb; 28(4):559-68. PubMed ID: 24076661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
